You have 9 free searches left this month | for more free features.

Luminal

Showing 26 - 50 of 1,212

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

Not yet recruiting
  • Triple-Negative Breast Cancer
  • Trastuzumab Deruxtecan
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jul 12, 2023

Advanced Breast Cancer Trial in Spain (CB-103)

Active, not recruiting
  • Advanced Breast Cancer
  • Alzira, Spain
  • +14 more
Jun 7, 2022

Metastatic Breast Cancer Trial in Murcia, Valencia

Recruiting
  • Metastatic Breast Cancer
    • Murcia, Spain
    • +1 more
    Nov 10, 2021

    Physical Exercise on Tumor Proliferation of Luminal B Breast

    Active, not recruiting
    • Breast Cancer
    • Luminal B
    • Exercise
    • Stretching
    • Madrid, Spain
      Hospital General Universitario Gregorio Marañón
    Feb 2, 2022

    Neoadjuvant Operable Breast Cancer Trial in Paris, Villejuif (Fluorouracile, Epirubicin, Cyclophosphamide)

    Completed
    • Neoadjuvant Operable Breast Cancer
    • Paris, France
    • +1 more
    Mar 14, 2022

    Metastatic Uveal Melanoma, Triple Negative Breast Cancer, Luminal B Breast Cancer Trial in Paris (Questionnaires,

    Recruiting
    • Metastatic Uveal Melanoma
    • +3 more
    • Questionnaires
    • +3 more
    • Paris, France
      Institut Curie
    Apr 6, 2022

    Recurrence in Early-stage Luminal Breast Cancer

    Not yet recruiting
    • Breast Cancer
    • Recurrence
      • (no location specified)
      Jul 12, 2021

      Ventilation Heterogeneity Prior to Lung Resection

      Enrolling by invitation
      • Lung Cancer
      • Hyperpolarized 129Xe MRI
      • +2 more
      • Hamilton, Ontario, Canada
        Firestone Institute for Respiratory Health, Research - St. Josep
      Jan 18, 2023

      Early-Stage Breast Carcinoma, Estrogen Receptor Positive Tumor Trial in Stockholm (Paclitaxel, Tamoxifen + Palbociclib,

      Active, not recruiting
      • Early-Stage Breast Carcinoma
      • Estrogen Receptor Positive Tumor
      • Stockholm, Sweden
      • +2 more
      Jul 30, 2021

      Breast Tumors Trial in Netherlands (Letrozole, Chemotherapy, Ribociclib plus letrozole)

      Active, not recruiting
      • Breast Neoplasms
      • 's-Hertogenbosch, Netherlands
      • +28 more
      Mar 4, 2022

      Female Breast Cancer Trial in Germany

      Recruiting
      • Female Breast Cancer
        • Moenchengladbach, NRW, Germany
        • +4 more
        Mar 30, 2023

        Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)

        Terminated
        • Breast Cancer
        • Breast Cancer Metastatic
        • Niraparib 100 MG
        • Aromatase Inhibitors
        • A Coruña, Spain
        • +9 more
        Jan 17, 2023

        Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer Trial in Algeria, Jordan, Saudi Arabia (Combination of

        Not yet recruiting
        • Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer
        • Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)
        • Blida, Algeria
        • +6 more
        Dec 28, 2021

        Breast Cancer Trial in Milan (Caelyx®)

        Active, not recruiting
        • Breast Cancer
        • Milan, Italy
          European Institute of Oncology
        Feb 11, 2021

        Predictive Factors of ANTI-TNF Response in Luminal Crohn's

        Completed
        • CD
          • Clichy, France
          • +1 more
          Jan 19, 2021

          Comparison of the Breast Tumor Microenvironment

          Recruiting
          • Triple Negative Breast Cancer
          • Hormone Receptor Positive Malignant Neoplasm of Breast
          • Breast tissue collection
          • Blood sample collection
          • New York, New York
            Columbia University Irving Medical Center
          Aug 18, 2021

          Ulcerative Colitis Trial in Rochester (Adipose derived, autologous mesenchymal stem cells)

          Recruiting
          • Ulcerative Colitis
          • Adipose derived, autologous mesenchymal stem cells
          • Rochester, Minnesota
            Mayo Clinic in Rochester
          Sep 29, 2021

          HER2-negative Early Breast Cancer Trial in Beijing (neoadjuvant chemo upon in vitro PTC drug sensitivity screening for triple

          Recruiting
          • HER2-negative Early Breast Cancer
          • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for triple negative breast cancer
          • neoadjuvant chemotherapy upon in vitro PTC drug sensitivity screening for luminal like breast cancer
          • Beijing, China
            Peking University People's Hospital
          Mar 27, 2022

          Local Recurrence Following Breast Conserving Surgery and

          Active, not recruiting
          • Breast Cancer
            • Calgary, Alberta, Canada
            • +26 more
            Sep 19, 2022

            Radiation Therapy, Breast Cancer, Sequential Partial Breast Irradiation, Intermediate and High-risk Luminal and Triple Negative

            Recruiting
            • Radiation Therapy, Breast Cancer, Sequential Partial Breast Irradiation
            • Intermediate and High-risk Luminal and Triple Negative Breast Cancer
            • Créteil, France
            • +5 more
            May 10, 2021

            Breast Cancer, Sentinel Lymph Node Biopsy, Neoadjuvant Chemo Trial in Rijeka

            Enrolling by invitation
            • Breast Cancer
            • +2 more
              • Rijeka, Croatia
                Ana Car Peterko
              Aug 2, 2021

              Learning MRI and Histology Image Mappings for Cancer Diagnosis

              Recruiting
              • Prostate Cancer
              • Prostate Neoplasm
              • VERDICT MRI
              • Luminal Index Imaging
              • London, United Kingdom
                University College London Hospital
              Mar 8, 2021

              Breast Cancer Trial in Italy (Epirubicin, Cyclophosphamide, Triptorelin)

              Completed
              • Breast Cancer
              • Cona, FE, Italy
              • +4 more
              Dec 2, 2020

              Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 Trial

              Recruiting
              • Anatomic Stage IA Breast Cancer AJCC v8
              • +27 more
              • Aspiration of Breast
              • Biospecimen Collection
              • Columbus, Ohio
                Ohio State University Comprehensive Cancer Center
              Oct 29, 2021

              Breast Cancer Trial in Spain (Atezolizumab + Trastuzumab + Vinorelbine)

              Recruiting
              • Breast Cancer
              • Atezolizumab + Trastuzumab + Vinorelbine
              • Granada, Andalucía, Spain
              • +14 more
              Mar 2, 2022